SPONSOR
Gulbenkian Institute for Molecular Medicine
Total Trials
1
Recruiting
1
Phases
N/A
Gulbenkian Institute for Molecular Medicine is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Colorectal Cancer (CRC), Microbiome, Early Onset Colorectal Cancer.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gulbenkian Institute for Molecular Medicine
How many clinical trials has Gulbenkian Institute for Molecular Medicine sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Gulbenkian Institute for Molecular Medicine, of which 1 are actively recruiting participants. These trials cover conditions including Colorectal Cancer (CRC), Microbiome, Early Onset Colorectal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gulbenkian Institute for Molecular Medicine research focus on?
Gulbenkian Institute for Molecular Medicine clinical trials span Colorectal Cancer (CRC), Microbiome, Early Onset Colorectal Cancer. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Gulbenkian Institute for Molecular Medicine clinical trial?
To participate in a Gulbenkian Institute for Molecular Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gulbenkian Institute for Molecular Medicine trials with current recruitment status updated daily.
Clinical Trials by Gulbenkian Institute for Molecular Medicine
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology